These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32905295)

  • 1. Evidence in chronic kidney disease-mineral and bone disorder guidelines: is it time to treat or time to wait?
    Bover J; Ureña-Torres P; Mateu S; DaSilva I; Gràcia S; Sánchez-Baya M; Arana C; Fayos L; Guirado L; Cozzolino M
    Clin Kidney J; 2020 Aug; 13(4):513-521. PubMed ID: 32905295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
    Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
    Uhlig K; Berns JS; Kestenbaum B; Kumar R; Leonard MB; Martin KJ; Sprague SM; Goldfarb S
    Am J Kidney Dis; 2010 May; 55(5):773-99. PubMed ID: 20363541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report.
    Wang AY; Akizawa T; Bavanandan S; Hamano T; Liew A; Lu KC; Lumlertgul D; Oh KH; Zhao MH; Ka-Shun Fung S; Obi Y; Sumida K; Choong LHL; Goh BL; Hao CM; Kwon YJ; Tarng DC; Zuo L; Wheeler DC; Tsukamoto Y; Fukagawa M
    Kidney Int Rep; 2019 Nov; 4(11):1523-1537. PubMed ID: 31890994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.
    Ketteler M; Block GA; Evenepoel P; Fukagawa M; Herzog CA; McCann L; Moe SM; Shroff R; Tonelli MA; Toussaint ND; Vervloet MG; Leonard MB
    Kidney Int; 2017 Jul; 92(1):26-36. PubMed ID: 28646995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.
    Holden RM; Mustafa RA; Alexander RT; Battistella M; Bevilacqua MU; Knoll G; Mac-Way F; Reslerova M; Wald R; Acott PD; Feltmate P; Grill A; Jindal KK; Karsanji M; Kiberd BA; Mahdavi S; McCarron K; Molnar AO; Pinsk M; Rodd C; Soroka SD; Vinson AJ; Zimmerman D; Clase CM
    Can J Kidney Health Dis; 2020; 7():2054358120944271. PubMed ID: 32821415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.
    Bellorin-Font E; Ambrosoni P; Carlini RG; Carvalho AB; Correa-Rotter R; Cueto-Manzano A; Jara A; Jorgetti V; Negri AL; Olaizola I; Salusky I; Slatopolsky E; Weisinger JR; ;
    Nefrologia; 2013; 33 Suppl 1():1-28. PubMed ID: 23629678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation and implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countries.
    Al Rukhaimi M; Al Sahow A; Boobes Y; Goldsmith D; Khabouth J; El Baz T; Mahmoud H; Ganji MR; Shaheen FA;
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):133-48. PubMed ID: 24434398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of chronic kidney disease-mineral and bone disorder in incident peritoneal dialysis patients and its association with short-term outcomes.
    Chuang SH; Wong HC; Vathsala A; Lee E; How PP
    Singapore Med J; 2016 Nov; 57(11):603-609. PubMed ID: 26778726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
    Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group
    Kidney Int Suppl; 2009 Aug; (113):S1-130. PubMed ID: 19644521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM).
    Torregrosa JV; Bover J; Rodríguez Portillo M; González Parra E; Dolores Arenas M; Caravaca F; González Casaus ML; Martín-Malo A; Navarro-González JF; Lorenzo V; Molina P; Rodríguez M; Cannata Andia J
    Nefrologia (Engl Ed); 2023 Jun; 43 Suppl 1():1-36. PubMed ID: 37202281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Current Perspectives.
    Waziri B; Duarte R; Naicker S
    Int J Nephrol Renovasc Dis; 2019; 12():263-276. PubMed ID: 31920363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Workup for Disorders of Bone and Mineral Metabolism in Patients with Chronic Kidney Disease in the Era of KDIGO Guidelines.
    Morrone LF; Russo D; Di Iorio B
    Int J Nephrol; 2011; 2011():958798. PubMed ID: 21603118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). KDIGO CKD-MBD Clinical Practice Guideline].
    Tsukamoto Y
    Clin Calcium; 2010 Jul; 20(7):1021-7. PubMed ID: 20585180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive Summary: Clinical Practice Guideline of Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) in China.
    Liu ZH; Li G; Zhang L; Chen J; Chen X; Zhao J; Liang X
    Kidney Dis (Basel); 2019 Oct; 5(4):197-203. PubMed ID: 31768376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kidney and bone update : the 5-year history and future of CKD-MBD. The changes after the introduction of CKD-MBD as a new entity].
    Koizumi M; Fukagawa M
    Clin Calcium; 2012 Jul; 22(7):969-77. PubMed ID: 22750928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.
    Ketteler M; Block GA; Evenepoel P; Fukagawa M; Herzog CA; McCann L; Moe SM; Shroff R; Tonelli MA; Toussaint ND; Vervloet MG; Leonard MB
    Ann Intern Med; 2018 Mar; 168(6):422-430. PubMed ID: 29459980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?
    Cozzolino M; Ureña-Torres P; Vervloet MG; Brandenburg V; Bover J; Goldsmith D; Larsson TE; Massy ZA; Mazzaferro S;
    Nephrol Dial Transplant; 2014 Oct; 29(10):1815-20. PubMed ID: 24516228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification.
    London G; Coyne D; Hruska K; Malluche HH; Martin KJ
    Clin Nephrol; 2010 Dec; 74(6):423-32. PubMed ID: 21084045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.